Company intelligence / Profile preview

Bank of China International

Hong Kong, Hong Kong SARbocionline.com ↗

Ownership: Private
Development stage: Other

Overview

BOCI is not itself a drug developer but provides investment banking and financial advisory services to companies in the healthcare, biotechnology, and pharmaceutical sectors. It is known for its role in capital markets transactions such as IPOs and M&A within these industries[7].

Industry: Investors

Partnerships

Acts as underwriter/advisor for numerous biotech/pharma IPOs/M&A deals.

Beyond the preview

Go deeper on Bank of China International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bank of China International.

Explore the full profile